
Keywords: CB1، گیرنده کانابینوئید نوع 1; Drug repurposing; Tuberculosis; Rimonabant; BM212; Sila analogue; MmpL3 inhibitorMIC, Minimum Inhibitory Concentration; ADME, absorption, distribution, metabolism, excretion; CB1, Cannabinoid receptor Type 1; Mtb, Mycobacterium tuberculosis; CNS, Central